JPH03109329A - Health agent - Google Patents
Health agentInfo
- Publication number
- JPH03109329A JPH03109329A JP1248621A JP24862189A JPH03109329A JP H03109329 A JPH03109329 A JP H03109329A JP 1248621 A JP1248621 A JP 1248621A JP 24862189 A JP24862189 A JP 24862189A JP H03109329 A JPH03109329 A JP H03109329A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- calcium
- agent
- health
- health agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 claims abstract description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000011575 calcium Substances 0.000 claims abstract description 7
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 7
- 210000003278 egg shell Anatomy 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract 3
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 abstract description 4
- 102000002322 Egg Proteins Human genes 0.000 abstract 2
- 108010000912 Egg Proteins Proteins 0.000 abstract 2
- 230000006866 deterioration Effects 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE:To obtain the title agent for health preservation at all times with the bone prevented from deterioration by mixing eggshell powder and tangle powder at a specified ratio. CONSTITUTION:The objective health agent can be obtained by mixing (A) as the main component, eggshell powder predominant in calcium with (B) tangle powder for preserving alkalinity in the body at the weight ratio A/B=10:2.
Description
【発明の詳細な説明】
従来、保纜騙Ｊとしてカルシウムを主体とする物は数多
く提案されているが、いまだ決定的の物は無いのが実情
である。DETAILED DESCRIPTION OF THE INVENTION In the past, many materials containing calcium as a main ingredient have been proposed as protective agents, but the reality is that there is still no definitive product.
（発明が解決しようとする課題）
本発明は種々永年にわたって研究し九結果、高齢になる
に従いカルシウムが不足し、これによって骨が弱くなっ
て思わず負傷を起こすことがあり日常において常にカル
シウムの補給をする必要を痛感するが適当の物が無いの
が実情で、本発明はより骨の老化を防止し健康に資せん
とするものである。(Problems to be Solved by the Invention) The present invention has been researched for many years and found that as we get older, we become deficient in calcium, which weakens our bones and can lead to injuries. Although we are acutely aware of the need to do so, the reality is that there is no suitable product, and the present invention aims to further prevent bone aging and contribute to health.
以下、本発明の実施例について説明すれば、卵として常
に服用せんとするものである。Hereinafter, an embodiment of the present invention will be described, in which the egg is always taken as an egg.
卵の殼を粉末にしたものには１００ｇ中に以下の成分を
有するものである（秦野研究所の分析）■ カルシウム
５５．８ｇ
■ リ ン ８２０ｎη（■
ナトリウＡ ５１０ｍｇ
■ カリウム ２５ｍｇ
■鉄 １８ｍｇ
この粉末を１０としてコンブの粉末を２の割合に混和す
る。コンブはアルカリを含有し、体内において酸性を阻
止してアルカリ性を保持するにあって、僅かな量で足り
るためその少量を添加するにある。Powdered egg shells have the following components per 100g (analysis by Hadano Research Institute) ■ Calcium 55.8g ■ Phosphorus 820nη (■
Sodium A 510mg ■ Potassium 25mg ■ Iron 18mg This powder is 10 parts and kelp powder is mixed in at a ratio of 2 parts. Kelp contains alkali, and only a small amount is needed to prevent acidity and maintain alkalinity in the body, so it is added in only a small amount.
（効 果）
この発明は以上のようにカルシウムを主体とし、カルシ
ウムの中には僅かながら鉄分を含み、更にコンブの粉末
を僅か加えることによって高齢化と共に骨の弱くなるの
を防止して常に健康と保つことができるものである。(Effects) As described above, this invention is mainly composed of calcium, which contains a small amount of iron, and by adding a small amount of kelp powder, it prevents bones from weakening with aging and helps people stay healthy. It is something that can be maintained.
Claims (1)
体としてこれにコンブの粉末をカルシウム１０に対し２
の割合に混和して成る保健剤。Powdered eggshells contain calcium, which is the main component of eggshells, and add kelp powder to 10 parts calcium to 2 parts.
A health agent that is mixed with the following proportions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1248621A JPH03109329A (en) | 1989-09-25 | 1989-09-25 | Health agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1248621A JPH03109329A (en) | 1989-09-25 | 1989-09-25 | Health agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03109329A true JPH03109329A (en) | 1991-05-09 |
Family
ID=17180839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1248621A Pending JPH03109329A (en) | 1989-09-25 | 1989-09-25 | Health agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03109329A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0819436A3 (en) * | 1996-07-19 | 1999-01-20 | Norbert Mag. Fuchs | Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators |
| US5948167A (en) * | 1995-09-29 | 1999-09-07 | Hyundai Electronics Industries Co., Ltd. | Thin film deposition apparatus |
-
1989
- 1989-09-25 JP JP1248621A patent/JPH03109329A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948167A (en) * | 1995-09-29 | 1999-09-07 | Hyundai Electronics Industries Co., Ltd. | Thin film deposition apparatus |
| EP0819436A3 (en) * | 1996-07-19 | 1999-01-20 | Norbert Mag. Fuchs | Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200001125A1 (en) | PHARMACEUTICAL PHARMACEUTICAL COMPOSITIONS | |
| EE03220B1 (en) | An oil-in-water emulsion, its use and a pharmaceutical composition containing it | |
| RU2010122170A (en) | COMPOSITIONS AND METHODS FOR IMPROVING THE CONDITION OF THE SKIN AND COAT | |
| ZA917371B (en) | Calcium uptake inhibitors | |
| AR019000A1 (en) | EMULSION AND PROCESS FOR PRODUCTION; GEL AND PROCESS FOR PRODUCTION; FUNCTIONAL INGREDIENT OF FOODS THAT UNDERSTAND THEM; FOOD, DRINK AND COSMETIC THAT INCLUDE SUCH EMULSION | |
| BR9810832A (en) | Pharmaceutical composition containing as active ingredients vitamin D associated with a calcium salt, and processes for the preparation of a pharmaceutical composition, for treating nutritional deficiencies of calcium and vitamin D in old age and to reduce the loss of bone tissue linked to age and to avoid femoral and other non-vertebral fractures | |
| BR9908526A (en) | Substitute for skimmed milk powder | |
| JPH03109329A (en) | Health agent | |
| IL115754A (en) | Liposomic composition containing selegilin and process for its preparation | |
| RIGGINS et al. | The effect of fluoride supplementation on the strength of osteopenic bone | |
| Panigrahi et al. | Effects on dietary phosphorus of treating cottonseed meal with crystalline ferrous sulphate for the prevention of brown yolk discolouration | |
| US4663165A (en) | Method for counteracting the adverse effects of sodium chloride | |
| EP0286601A3 (en) | Powdered deodorant composition for shoes, in particular for sporting shoes | |
| US8575223B2 (en) | Cream for applying on a body | |
| EP0326963B1 (en) | Deodorant as well as deodorizing food, drink and seasoning | |
| HU913009D0 (en) | Method for producing inhibitors of calcium ingestion | |
| JPH02242655A (en) | Meterial reducing adverse reaction of kitchen salt | |
| CA2037788A1 (en) | Quality-improving agents for fish meat surimi | |
| RU2250046C1 (en) | Biologically active calcium-containing amaranthus-based additive for compensating calcium deficiency and normalizing calcium body exchange | |
| Soni et al. | Effect of feeding graded calcium with excess fluoride on the growth and bone mineral status of weanling albino rats | |
| JP2003063970A (en) | Anti-osteoporosis composition | |
| PT102095A (en) | Prolonged-action composition of granules containing 4- nitro-2-phenoxymethanosulfonilide and method for its preparation | |
| WO2012004782A2 (en) | Oral remedial mineral replenishment (omr) preparation | |
| JP2973102B2 (en) | Food production method using crow's egg | |
| Grenby | Caries inhibiting chemicals |